ID Genomics
ID Genomics is dedicated to personalized diagnostics for infectious diseases, combining rapid molecular diagnostics with epidemiological surveillance and big-data tools to guide antibiotic choices. Their innovative products, such as CLoNeT™ and BactNeT™, aim to improve clinical outcomes, reduce antibiotic prescription errors, and combat antibiotic resistance. They offer a range of services including microbial identification, typing, genomic analysis, and SARS-CoV-2 sequencing, with a focus on advancing infectious disease diagnostics and surveillance.
Industries
Nr. of Employees
small (1-50)
ID Genomics
Seattle, Washington, United States, North America
Products
Rapid barcode-based bacterial diagnostic (developmental)
A rapid diagnostic approach that uses targeted DNA fingerprint regions to assign short DNA 'barcodes' to infecting bacteria to inform antibiotic selection; early-generation products target urinary tract infections and are undergoing clinical observational evaluation.
Reference metadata repository linking sequence identifiers to antibiotic responses
A metadata platform that links bacterial samples, sequence-derived identifiers (barcodes), and clinical antibiotic response data to support surveillance and inform prescribing.
Curated pathogenic bacterial strain collection
Collections of pathogenic bacterial strains, including clinically important resistant phenotypes (e.g., CRE, ESBL, MDR/XDR strains), offered for use in antimicrobial testing and research.
Rapid barcode-based bacterial diagnostic (developmental)
A rapid diagnostic approach that uses targeted DNA fingerprint regions to assign short DNA 'barcodes' to infecting bacteria to inform antibiotic selection; early-generation products target urinary tract infections and are undergoing clinical observational evaluation.
Reference metadata repository linking sequence identifiers to antibiotic responses
A metadata platform that links bacterial samples, sequence-derived identifiers (barcodes), and clinical antibiotic response data to support surveillance and inform prescribing.
Curated pathogenic bacterial strain collection
Collections of pathogenic bacterial strains, including clinically important resistant phenotypes (e.g., CRE, ESBL, MDR/XDR strains), offered for use in antimicrobial testing and research.
Services
16S rRNA Analysis (isolate identification)
Sequencing-based identification of unknown bacterial isolates using 16S rRNA variable regions with reference library matching and phylogenetic analysis.
16S rRNA Metagenomics Analysis
Culture-free NGS-based profiling of microbial communities targeting 16S V3–V5 regions to produce biodiversity and functional composition profiles.
ITS Microbiome Testing (Fungi)
Sequencing-based analysis of fungal community composition using ITS regions.
MLST sequence typing
High-resolution sequence typing by sequencing multiple standardized loci and assigning sequence types for epidemiology and strain discrimination.
Staphylococcus aureus spa typing
Single-locus VNTR sequencing of the spa gene for S. aureus subtyping to support epidemiological investigations and comparison with MLST-level data.
Antibiotic susceptibility testing (disc-diffusion)
Phenotypic disc-diffusion (Kirby–Bauer) testing performed according to CLSI M100S recommendations for bacterial samples up to BSL-2.
16S rRNA Analysis (isolate identification)
Sequencing-based identification of unknown bacterial isolates using 16S rRNA variable regions with reference library matching and phylogenetic analysis.
16S rRNA Metagenomics Analysis
Culture-free NGS-based profiling of microbial communities targeting 16S V3–V5 regions to produce biodiversity and functional composition profiles.
ITS Microbiome Testing (Fungi)
Sequencing-based analysis of fungal community composition using ITS regions.
MLST sequence typing
High-resolution sequence typing by sequencing multiple standardized loci and assigning sequence types for epidemiology and strain discrimination.
Staphylococcus aureus spa typing
Single-locus VNTR sequencing of the spa gene for S. aureus subtyping to support epidemiological investigations and comparison with MLST-level data.
Antibiotic susceptibility testing (disc-diffusion)
Phenotypic disc-diffusion (Kirby–Bauer) testing performed according to CLSI M100S recommendations for bacterial samples up to BSL-2.
Expertise Areas
- Microbial identification and typing
- Metagenomic community profiling
- Fungal ITS-based analysis
- Antimicrobial susceptibility testing
Key Technologies
- Next-generation sequencing (NGS)
- 16S rRNA variable-region sequencing (V3-V5)
- ITS sequencing for fungi
- Multi-locus sequence typing (MLST)